|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 413/12 | (2006.01) |
| A61K 31/513 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 1819700 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05852840.7 |
| Date of filing the European patent application | 2005-12-02 | |
| (97) | Date of publication of the European application | 2007-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2011-11-23 |
| (46) | Date of publication of the claims translation | 2012-04-25 |
| (86) | Number | PCT/US2005/043728 |
| Date | 2005-12-02 |
| (87) | Number | WO 2006/060712 |
| Date | 2006-06-08 |
| (30) | Number | Date | Country code |
| 633132 P | 2004-12-03 | US |
| (72) |
BELYK, Kevin, M., US
MORRISON, Henry, G., US
JONES, Philip, IT
SUMMA, Vincenzo, IT
|
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
MSD ITALIA S.r.l., Via Vitorchiano 151, 00189 Roma, IT |
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | ŽIV integrazės inhibitoriaus kalio druska |
| POTASSIUM SALT OF AN HIV INTEGRASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-11-12 | 347.00 EUR |